Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
The Ultimate Guide to Choosing the Best Insulation for Your Ceiling
$123.00Original price was: $123.00.$122.00Current price is: $122.00.Add to cartWhen it comes to insulating your home, the ceiling plays a crucial role in maintaining a comfortable indoor environment. The right insulation can significantly improve energy efficiency, reduce utility bills, and enhance overall comfort. In this comprehensive guide, we will explore the various types of insulation available for ceilings and help you make an informed …
The Ultimate Guide to Choosing the Best Insulation for Your CeilingRead More
-
Quick View
Phasellus molestie id mi sit amet
$66.00Add to cartMorbi mattis ipsum sem, in gravida dolor venenatis vestibulum. Aenean laoreet, nisi in bibendum dictum, purus libero accumsan enim, id vehicula enim metus vitae ipsum. Maecenas nulla est, dictum quis augue ultrices, dictum rutrum enim. Aliquam erat volutpat.
-
Quick View
Nulla feugiat felis tempor sem
$61.00Add to carteget ullamcorper leo auctor. Donec at interdum nibh, in blandit massa. Nam pulvinar mollis quam, vel fringilla mi interdum elementum. Donec ullamcorper turpis et libero sagittis vestibulum. Donec enim nisl, rhoncus vitae magna eu, convallis tempus tortor. Integer et facilisis metus.
-
Quick View
Nunc tempus facilisis
$87.00Add to cartFusce ullamcorper dapibus eleifend. Nullam ornare pulvinar lacinia. Nunc tempus facilisis ullamcorper. Nam sit amet suscipit risus, ut ultricies felis. Vivamus a finibus nisi. Sed quam sem, accumsan eget tristique sit amet, suscipit sit amet augue. Duis dolor dui, sagittis at faucibus ac, varius et sapien.






Reviews
There are no reviews yet.